Decarboxylation of exogenous L-DOPA in rat striatum after lesions of the dopaminergic nigrostriatal neurons: the role of striatal capillaries

[1]  R. Wurtman,et al.  Diminished decarboxylation of l-dopa in rat striatum after intrastriatal injections of kainic acid , 1980, Neuropharmacology.

[2]  R. Wurtman,et al.  Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease , 1980, Nature.

[3]  F. Hefti.  A simple, sensitive method for measuring 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detection. , 1979, Life sciences.

[4]  P. Kissinger,et al.  DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHY , 1978, Journal of neurochemistry.

[5]  R. Duvoisin,et al.  Where isl-DOPA decar☐ylated in the striatum after 6-hydroxydopamine nigrotomy? , 1978, Brain Research.

[6]  S. Spector,et al.  Studies on the monoamine oxidase and catechol-O-methyltransferase of the rat cerebral microvessels. , 1978, Archives internationales de pharmacodynamie et de therapie.

[7]  O. Hornykiewicz,et al.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy. , 1975, The Journal of pharmacology and experimental therapeutics.

[8]  R. Katzman.,et al.  Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection. , 1975, The American journal of physiology.

[9]  O. Hornykiewicz.  The mechanisms of action of L-dopa in Parkinson's disease. , 1974, Life sciences.

[10]  R. Boucher,et al.  Effects of chronically administered L-dopa in normal and lesioned cats. , 1973, The Journal of pharmacology and experimental therapeutics.

[11]  H. Mars.  Modification of levodopa effect by systemic decarboxylase inhibition. , 1973, Archives of neurology.

[12]  T. Chase,et al.  L‐dopa in parkinsonism , 1972, Neurology.

[13]  R. Wurtman,et al.  Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain. , 1972, The Journal of pharmacology and experimental therapeutics.

[14]  W H Oldendorf,et al.  Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. , 1971, The American journal of physiology.

[15]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[16]  N. Weiner,et al.  Assay of tyrosine hydroxylase by coupled decarboxylation of DOPA formed from 1- 14 C-L-tyrosine. , 1971, Analytical biochemistry.

[17]  A. Pletscher,et al.  Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine , 1969, The Journal of pharmacy and pharmacology.

[18]  Å. Bertler,et al.  The localization of monoaminergic blood-brain barrier mechanisms. , 1966, Pharmacological reviews.

[19]  M. Vogt.  Drug-induced changes in brain dopamine and their relation to parkinsonism. , 1970, The Scientific basis of medicine annual reviews.